Spatial Repellents for the Prevention of Malaria in Kenya
NCT04766879 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5984
Last updated 2024-04-15
Summary
Spatial repellents are chemical-based devices that when placed in a room, make that room non-conducive for mosquitoes. These tools can be used to help in the fight against vector borne diseases such as malaria and dengue. However, their efficacy in reducing mosquito biting and therefore malaria transmission has never been evaluated in Africa. This study will evaluate the efficacy of a spatial repellent in reducing mosquito biting on human beings and measure the impact any reduced biting will have on malaria transmission. The investigators will recruit and follow-up 5,984 children between 6 months and \<10 years of age in Busia County to determine how many times they will be infected with malaria in villages where the investigators will have distributed spatial repellents and compare the rate of infection to villages where the investigators will not have distributed the repellent devices. Additionally, the investigators will measure whether the distribution of spatial repellents in one village will drive mosquitoes to their neighboring houses thereby increasing malaria transmission in those areas. The children participating in the study will be divided into 3 groups (cohorts). The first group will be followed up during the first 4 months before any intervention is distributed and the purpose here will be to determine that the villages are comparable. After this, the investigators will recruit the next group of participants and follow them up for 1 year and repeat this again for another year. During the follow-up, the children will be asked to come to the health facility where they will be tested for malaria using RDT or blood slide for microscopy. Every two weeks, a member of the study team will come to the participant's house and ask them if they had any history of fever. If the participants had fever, they will be tested for malaria. All children who turn out to be positive for malaria by RDT will be treated free of charge. At the same time, the investigators shall also perform mosquito collections to determine the impact of spatial repellents on the density of Anopheles mosquitoes.
Conditions
Interventions
- DEVICE
-
Transfluthrin
Passive emanator with formulated transfluthrin
- DEVICE
-
Placebo
Passive emanator with formulated inert ingredients
Sponsors & Collaborators
-
S.C. Johnson & Son, Inc.
collaborator INDUSTRY -
Kenya Medical Research Institute
collaborator OTHER -
Centers for Disease Control and Prevention
collaborator FED -
fhiClinical
collaborator UNKNOWN -
University of Notre Dame
lead OTHER
Principal Investigators
-
John P Grieco, Ph.D. · University of Notre Dame
-
Eric Ochomo, Ph.D. · Kenya Medical Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-02
- Primary Completion
- 2023-10-23
- Completion
- 2023-12-09
Countries
- Kenya
Study Locations
More Related Trials
-
Evaluating ATSBs for Malaria Reduction in Kenya
NCT05219565 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in Uganda
NCT06232954 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria Incidence
NCT02392832 ·Status: COMPLETED ·Phase: NA
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia
NCT05117567 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya
NCT02987270 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia
NCT04241705 ·Status: UNKNOWN ·Phase: NA
-
Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania
NCT05874869 ·Status: COMPLETED ·Phase: NA
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar
NCT05025761 ·Status: UNKNOWN ·Phase: NA
-
P. Falciparum Infection Dynamics and Transmission to Inform Elimination (INDIE-1a)
NCT03705624 ·Status: COMPLETED ·Phase: NA
-
Malaria High-Risk Populations in Namibia
NCT04094727 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda
NCT05323721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan
NCT05471544 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
NCT04695197 ·Status: COMPLETED ·Phase: PHASE3
-
Emptying Malaria Reservoirs to Accelerate Malaria Elimination in High Transmission Settings
NCT05440773 ·Status: UNKNOWN ·Phase: NA
-
RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi
NCT04327440 ·Status: COMPLETED
-
Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine
NCT01878357 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi
NCT01326754 ·Status: COMPLETED ·Phase: NA
-
Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia
NCT02329301 ·Status: COMPLETED ·Phase: NA
-
IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding
NCT06870344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mass-Drug Administration to Reduce Malaria Transmission
NCT00509015 ·Status: COMPLETED ·Phase: NA
-
PDMC Implementation Trial in Kenya
NCT06624631 ·Status: RECRUITING ·Phase: PHASE4
-
Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)
NCT01939886 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria
NCT00902811 ·Status: UNKNOWN ·Phase: PHASE4
-
Therapeutic Efficacy Study of AL and DP in Western Kenya
NCT05060198 ·Status: COMPLETED ·Phase: NA
-
Controlled Human Malaria Infection Transmission Model - Phase A
NCT04280692 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2